Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-27 22:49:23 - browse：3194

Alnylam headquarters — Kristoffer Tripplaar/Sipa USA/AP

Alnylam Pharmaceuticals said Thursday that sales of its treatments for rare diseases grew 43% in the second quarter compared to the year-ago period, as the biotech prepares for a key meeting with the Food and Drug Administration in September.

Net product sales in the quarter were $306 million, led by Amvuttra, the company’s RNAi treatment for hereditary ATTR, with sales of $132 million, exceeding Wall Street forecasts. Sales of Onpattro, its older medicine for hereditary ATTR, were $91 million, slightly less than expectations.

The FDA has scheduled a meeting of outside experts on Sept. 13 to discuss the company’s application to expand the indication for Onpattro to include ATTR-CM, a related condition that affects the heart. The FDA decision is due by Oct. 8. An expansion would open a much larger market for the drug than its current approval, which largely targets nerve-related damage.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Telehealth startups are trying to fill the menopause care vacuum

WSS

Sanders wants to replace patents with prizes for drug inventions

Are infertility treatments 'essential' during the Covid

After a decade, new Gardasil ad campaign gets it (mostly) right

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

Russian court extends detention of American musician

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

focus

Wikipedia

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Hepatitis C has a cure — but many Americans still lack access to it

Extensive review finds private equity owners jack up cost of care

As demand for Covid shots wanes, Moderna seeks its next success

Scientists find bacteria from stomach of ancient iceman

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Special counsel alerts court to Trump’s social media post

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Medical schools are missing the mark on artificial intelligence

knowledge

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Parkland mass shooting to be reenacted for lawsuit

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

When a patient nears the end, a feared therapy can comfort

Delta passengers in Vegas fall sick while waiting on flight in triple

knowledge

entertainment

Wikipedia

focus